Roche Holding AG (OTCMKTS:RHHBY – Free Report) – Erste Group Bank upped their FY2026 earnings per share (EPS) estimates for shares of Roche in a report issued on Thursday, August 27th. Erste Group Bank analyst H. Engel now forecasts that the company will post earnings of $3.16 per share for the year, up from their prior estimate of $3.15. The consensus estimate for Roche’s current full-year earnings is $3.06 per share. Erste Group Bank also issued estimates for Roche’s FY2027 earnings at $3.42 EPS.
Other equities analysts also recently issued research reports about the stock. Zacks Research raised shares of Roche from a “strong sell” rating to a “hold” rating in a research note on Monday, August 24th. HSBC cut shares of Roche from a “buy” rating to a “hold” rating in a research report on Monday, July 6th. Finally, Morgan Stanley upgraded Roche from an “equal weight” rating to an “overweight” rating and set a $63.00 price target for the company in a report on Friday, August 7th. Five research analysts have rated the stock with a Buy rating and six have given a Hold rating to the stock. According to MarketBeat.com, the company currently has an average rating of “Hold” and a consensus target price of $60.00.
Roche Stock Performance
OTCMKTS:RHHBY opened at $53.70 on Monday. The company has a debt-to-equity ratio of 0.72, a current ratio of 1.38 and a quick ratio of 1.12. Roche has a fifty-two week low of $39.50 and a fifty-two week high of $60.85. The company has a 50 day simple moving average of $54.03 and a two-hundred day simple moving average of $52.90.
Institutional Investors Weigh In On Roche
A number of institutional investors and hedge funds have recently made changes to their positions in the business. McIlrath & Eck LLC bought a new stake in Roche during the first quarter worth $39,000. Atlas Capital Advisors Inc. bought a new position in shares of Roche during the fourth quarter valued at about $192,000. Pinnacle Wealth Management Advisory Group LLC bought a new position in shares of Roche during the first quarter valued at about $208,000. Renasant Bank purchased a new position in Roche during the second quarter worth about $210,000. Finally, Enterprise Financial Services Corp boosted its holdings in Roche by 6.6% during the first quarter. Enterprise Financial Services Corp now owns 5,576 shares of the company’s stock worth $277,000 after purchasing an additional 345 shares during the last quarter.
Roche Company Profile
Roche Holding AG is a Swiss multinational healthcare company headquartered in Basel, founded in 1896 by Fritz Hoffmann‑La Roche. The company operates primarily through two complementary divisions — Pharmaceuticals and Diagnostics — and is known for integrating drug development with diagnostic capabilities to advance personalized healthcare. In the United States and other international markets, shares trade as American Depositary Receipts under the ticker RHHBY (OTCMKTS:RHHBY).
In pharmaceuticals, Roche focuses on developing and commercializing prescription medicines across therapeutic areas including oncology, immunology, infectious diseases and neuroscience, with a notable emphasis on targeted biologics and personalized therapies.
Featured Articles
- Five stocks we like better than Roche
- Securing AI: 5 Most-Upgraded Stocks From the Q2 Reporting Season
- Insiders Are Betting Big on These 3 Healthcare Stocks
- 3 Stocks for Investors Who Still Believe Cash Is King
- Dollar General and Dollar Tree Are Recovering, But Not for the Same Reason
Receive News & Ratings for Roche Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Roche and related companies with MarketBeat.com's FREE daily email newsletter.
